Target
Bromodomain testis-specific protein [22-138]
Ligand
BDBM550493
Substrate
n/a
Meas. Tech.
ATPLITE assay
IC50
142±n/a nM
Citation
 Bradner, JEQi, JTanaka, MBuckley, D Cyano thienotriazolodiazepines and uses thereof US Patent  US11306105 Publication Date 4/19/2022 
Target
Name:
Bromodomain testis-specific protein [22-138]
Synonyms:
BRDT | BRDT_HUMAN | Bromodomain testis-specific protein (BRDT)(BD1)
Type:
n/a
Mol. Mass.:
13948.58
Organism:
Homo sapiens (Human)
Description:
Q58F21[22-138]
Residue:
117
Sequence:
TKKNGRLTNQLQYLQKVVLKDLWKHSFSWPFQRPVDAVKLQLPDYYTIIKNPMDLNTIKKRLENKYYAKASECIEDFNTMFSNCYLYNKPGDDIVLMAQALEKLFMQKLSQMPQEEQ
  
Inhibitor
Name:
BDBM550493
Synonyms:
US11306105, Compound 109
Type:
Small organic molecule
Emp. Form.:
C22H20F2N6OS
Mol. Mass.:
454.496
SMILES:
Cc1sc-2c(c1C)C(=N[C@@H](CC(=O)NCC(F)F)c1nnc(C)n-21)c1ccc(cc1)C#N |r,c:8|
Structure:
Search PDB for entries with ligand similarity: